Mak Capital One Llc Buys Yatra Online Inc, Achillion Pharmaceuticals Inc, Global Blood Therapeutics Inc, Sells PTC Therapeutics Inc

Mar 06, 2019

New York, NY, based Investment company Mak Capital One Llc buys Yatra Online Inc, Achillion Pharmaceuticals Inc, Global Blood Therapeutics Inc, sells PTC Therapeutics Inc during the 3-months ended 2018Q4, according to the most recent filings of the investment company, Mak Capital One Llc. As of 2018Q4, Mak Capital One Llc owns 7 stocks with a total value of $185 million. These are the details of the buys and sells.

New Purchases: GBT,
Added Positions: YTRA, ACHN,
Reduced Positions: SKY, MXWL,
Sold Out: PTCT,

For the details of MAK CAPITAL ONE LLC's stock buys and sells, go to https://www.gurufocus.com/guru/mak+capital+one+llc/current-portfolio/portfolio

These are the top 5 holdings of MAK CAPITAL ONE LLC

Skyline Champion Corp (SKY) - 5,539,759 shares, 44.08% of the total portfolio. Shares reduced by 17.19%
Agilysys Inc (AGYS) - 5,284,648 shares, 41.04% of the total portfolio.
Achillion Pharmaceuticals Inc (ACHN) - 5,191,600 shares, 4.47% of the total portfolio. Shares added by 166.77%
Yatra Online Inc (YTRA) - 1,938,559 shares, 4.22% of the total portfolio. Shares added by 1566.45%
Maxwell Technologies Inc (MXWL) - 2,725,992 shares, 3.06% of the total portfolio. Shares reduced by 6.62%

New Purchase: Global Blood Therapeutics Inc (GBT)

Mak Capital One Llc initiated holding in Global Blood Therapeutics Inc. The purchase prices were between $31.54 and $46.67, with an estimated average price of $37.55. The stock is now traded at around $52.38. The impact to a portfolio due to this purchase was 2.14%. The holding were 96,040 shares as of .

Added: Yatra Online Inc (YTRA)

Mak Capital One Llc added to a holding in Yatra Online Inc by 1566.45%. The purchase prices were between $3.9 and $5.52, with an estimated average price of $4.81. The stock is now traded at around $4.00. The impact to a portfolio due to this purchase was 3.97%. The holding were 1,938,559 shares as of .

Added: Achillion Pharmaceuticals Inc (ACHN)

Mak Capital One Llc added to a holding in Achillion Pharmaceuticals Inc by 166.77%. The purchase prices were between $1.31 and $3.89, with an estimated average price of $2.8. The stock is now traded at around $2.76. The impact to a portfolio due to this purchase was 2.79%. The holding were 5,191,600 shares as of .

Sold Out: PTC Therapeutics Inc (PTCT)

Mak Capital One Llc sold out a holding in PTC Therapeutics Inc. The sale prices were between $29.83 and $45.28, with an estimated average price of $35.64.

Here is the complete portfolio of MAK CAPITAL ONE LLC. Also check out:

1. MAK CAPITAL ONE LLC's Undervalued Stocks
2. MAK CAPITAL ONE LLC's Top Growth Companies, and
3. MAK CAPITAL ONE LLC's High Yield stocks
4. Stocks that MAK CAPITAL ONE LLC keeps buying

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Data is updated daily.